Use of the SiDTM v2.0 Algorithm to Assist Embiyologists in Sperm Selection During ICSI Procedures

NCT07163754 — Not applicable, Not yet recruiting, 100 participants, Instituto Valenciano de Infertilidad, IVI VALENCIA

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

Use of the SiDTM v2.0 Algorithm to Assist Embryologists in Sperm Selection During ICSI Procedures: Impact in Biological and Clinical Outcomes

RegistryNCT07163754, acronym SID_3
StatusNot yet recruiting
PhaseNot applicable
Study typeInterventional; randomized, parallel, masking: none, health services research
Enrollment100 (Estimated)
SponsorInstituto Valenciano de Infertilidad, IVI VALENCIA (Other); collaborators: IVF 2.0 Limited
ConditionsMale Fertility, Testicular, Sperm Parameters in Fertile and Infertile Men, Sperm Selection
InterventionsAutomated Sperm Selection, Conventional Sperm Selection (Diagnostic test)
Datesstart 2025-10-01 (estimated), primary completion 2027-10-01 (estimated), completion 2027-10-01 (estimated), first posted 2025-09-09, last updated 2025-09-09

Related Papers Related Patents Related Grants Related Experts
All trials for Male Fertility All trials for Testicular All trials of Automated Sperm Selection All trials of Conventional Sperm Selection

-Summary

Infertility is defined as a failure of a couple to achieve a pregnancy after 12 or more months of unprotected intercourse. Males are found to be solely responsible for 20-30% of infertility cases but contribute to 50% of cases overall. The selection of sperm to microinject is completely subjective and there is high intra- and inter- observer variability. SiDTM v2.0 is an algorithm which analyses real-time seminal samples located at ICSI dishes. Particularly, it assesses morphology and several motility parameters of each sperm, and it assigns a categorical and numerical score to each one. Categorical scores are represented by colours: green colour for optimal sperm, yellow for good sperm, orange for medium-quality sperm and red for low-quality sperm. Numerical scores ranged from 0 to 100, with higher scores for those best-quality sperm. SiDTM v2.0 can reduce subjectivity of the sperm selection process to the maximum, selecting the optimal sperm in real time. In addition, it could help junior embryologists to perform this complex and tedious procedure, which is the sperm selection for ICSI. To carry out the study, we will conduct a prospective cohort study in a total of 100 couples. Therefore, the aim of this study is to validate SiDTM v2.0 as an useful Artificial Intelligence-tool for sperm selection; that means achieving , at least, same clinical results as sperm selection performed by the embryologist.

Expand all sections  ·  Collapse all

+Arms and interventions

ArmTypeInterventionsDescription
SIDExperimentalDiagnostic Test: Automated Sperm SelectionHalf of the MII oocytes obtained will be microinjected with spermatozoa selected by SiD TM
NO-SIDActive comparatorDiagnostic Test: Conventional Sperm SelectionHalf of the MII oocytes obtained will be microinjected with spermatozoa selected by embriologist.
  • Automated Sperm Selection (Diagnostic test): This group of oocytes will be microinjected with sperm selected by the second version of SID TM (SID V2.0) wich analyses additional sperm parameters than first version of SID TM (SID V1.0).
  • Conventional Sperm Selection (Diagnostic test): Half of the oocytes will be microinjected with sperm selected by the embryologist without SID assistance, based on the conventional and visual assesment of seminal samples located at ICSI dishes.

+Outcome measures

Primary outcomes

  • SID TM V2.0 VALIDATION [1 year]: The main objective of this study is to test whether assisted sperm selection using the artificial intelligence algorithm SiDTM v2.0 equals or exceeds the mean rate of useful blastocysts obtained by conventional unassisted sperm selection by SiDTM v2.0.

Secondary outcomes

  • Fertilization assesment (SID vs NO SID) [1 year]: Fertilization rate (SID VS NO SID)
  • Embryo development assesment (SID vs NO SID) [1 year]: Embryo development rate (SID VS NO SID)
  • Clinical outcomes assesment (SID vs NO SID) [1 year]: Gestation rate.
  • Clinical outcomes assesment (SID vs NO SID) [1 year]: Implantation rate
  • Clinical outcomes assesment (SID vs NO SID) [1 year]: Live birth rate.

+Eligibility

Sex: All, ages: 18 Years to any

Inclusion Criteria:

* Patients with indication for ICSI.
* Women of advanced maternal age (>35 years) in whom at least 4 oocytes in metaphase II stages are obtained in the follicular puncture, without excluding patients from the oocyte donation program.
* Sperm obtained by masturbation with a concentration above 1 million spermatozoa/mL after sperm capacitation.
* Normal karyotype of both partners.
* Informed Consent (IC).

Exclusion Criteria:

* Patients diagnosed with recurrent gestational loss.
* Semen extracted by testicular biopsy.
* Semen samples with globozoospermia (sperm defect due to lack of acrosome) or azoospermia (absence of spermatozoa in the ejaculate).
* Semen samples treated with pentoxifylline.
* ICSI cycles with application of calcium ionophore. o ICSI cycles with application of calcium ionophore.

+Publications

  • Montjean D, Godin Page MH, Pacios C, Calve A, Hamiche G, Benkhalifa M, Miron P. Automated Single-Sperm Selection Software (SiD) during ICSI: A Prospective Sibling Oocyte Evaluation. Med Sci (Basel). 2024 Mar 27;12(2):19. doi: 10.3390/medsci12020019. PMID 38651413
  • Mendizabal-Ruiz G, Chavez-Badiola A, Aguilar Figueroa I, Martinez Nuno V, Flores-Saiffe Farias A, Valencia-Murilloa R, Drakeley A, Garcia-Sandoval JP, Cohen J. Computer software (SiD) assisted real-time single sperm selection associated with fertilization and blastocyst formation. Reprod Biomed Online. 2022 Oct;45(4):703-711. doi: 10.1016/j.rbmo.2022.03.036. Epub 2022 Apr 10. PMID 35989168
  • Carrión-Sisternas, L., Bori, L., Conversa, L., Viloria, T., Tejera, A. AUTOMATED REAL-TIME SPERM SELECTION FOR INTRACYTOPLASMIC SPERM INJECTION (ICSI): SIBLING OOCYTE EVALUATION. Fertility and Sterility, Volume 122, Issue 4, e350
  • Asada Y. Evolution of intracytoplasmic sperm injection: From initial challenges to wider applications. Reprod Med Biol. 2024 May 27;23(1):e12582. doi: 10.1002/rmb2.12582. eCollection 2024 Jan-Dec. PMID 38803410

+Investigators